XML 44 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Business Combination (Details Narrative) - USD ($)
3 Months Ended
Aug. 21, 2020
Aug. 21, 2020
Mar. 03, 2020
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Aug. 18, 2020
Non-controlling interest       $ 3,399,000   $ 3,430,000  
Common stock, par value       $ 0.02   $ .02  
Issuance of common stock, net, shares          
Issuance of common stock, net       $ 61,068,000 $ 4,054,000    
Impact BioMedical, Inc. [Member]              
Incurred cost       420,000      
Cost attributable to non-controlling interest       $ 9,000      
Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]              
Equity ownership percentage             19.99%
Maximum [Member] | Impact BioMedical, Inc. [Member]              
Equity ownership percentage 100.00% 100.00%          
Minimum [Member] | Impact BioMedical, Inc. [Member]              
Equity ownership percentage 63.60% 63.60%          
IPO [Member]              
Initial public offering percentage       50.00%      
IPO [Member] | Maximum [Member]              
Shares issued price per share       $ 10.00      
American Medical Reit Inc. [Member]              
Debt principal amount       $ 844,000      
AMRE Asset Management Inc. [Member]              
Equity ownership percentage       52.50%      
Incurred cost       $ 58,000      
Non-controlling interest       $ 22,000      
Term Sheet [Member] | American Medical Reit Inc. [Member]              
Debt principal amount     $ 800,000        
Debt instrument interest rate percentage     8.00% 8.00%      
Debt maturity date     Mar. 03, 2022        
Number of warrant to purchase shares of common stock     160,000        
Warrant exercise price per share     $ 5.00        
Warrant expiration date     Mar. 03, 2024        
Unsecured promissory note       $ 200,000      
Term Sheet [Member] | AMRE Asset Management Inc. [Member]              
Equity ownership percentage     52.50%        
Term Sheet [Member] | American Medical Reit Inc. [Member]              
Equity ownership percentage     93.00%        
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member]              
Equity ownership percentage 100.00% 100.00%          
Shares issued price per share $ 6.48 $ 6.48          
Shares issued during acquisition 483,334            
Common stock, par value $ 0.02 $ 0.02          
Issuance of common stock, net, shares   483,334          
Share Exchange Agreement [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]              
Shares issued price per share $ 1,000 $ 1,000          
Issuance of common stock, net, shares 46,868            
Issuance of common stock, net $ 46,868,000            
Consideration value 50,000,000            
Back-Solve [Member] | Impact BioMedical, Inc. [Member] | Series A Convertible Preferred Stock [Member]              
Issuance of common stock, net 35,187,000            
Consideration value 38,319,000            
General and administrative expenses $ 295,000